About this event
- Date and time Tue 14 Mar 2023 from 8:30am to 5:45pm
- Location Royal Society of Medicine
- Organised by Vascular, Lipid and Metabolic Medicine Section, Cardiology, Endocrinology and Diabetes, General Practice with Primary Healthcare
Attend this event to learn about the pathophysiology, evidence-based management and state-of-the-art prevention strategies for non-communicable cardiometabolic diseases. The speakers will explore how obesity, diabetes, dyslipidaemia, hypertension, renal disease and metabolic liver disease increase the risk of vascular disease with associated morbidity and premature mortality.
The event will examine barriers to best care in primary and secondary care settings and the potential of new technologies to improve the management of patients with cardiometabolic disease.
This unique event aims to bridge across clinical specialties to improve care and outcomes for this growing, high-risk population.
Attendees will be able to:
- Understand the pathophysiology and shared characteristics of cardiometabolic disorders
- Become aware of recent advances in prevention and management
- Deliver more effective care for high-risk patients and improve clinical outcomes
To attend this event you must be a healthcare professional. On the day, please bring a form of identification with your GMC number to prove your status.
This event is run in association with the Cardiology, Primary Care and Endocrinology & Diabetes Sections.
A tailored reading list of extra educational resources has been created by our library teams specifically for this event and will be made available to you.
RSM members are able to access the full list of resources. To benefit from many of the resources in this list – become a member.
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
We would like to thank our sponsors Amarin, AstraZeneca, Daiichi Sankyo UK Ltd and Novartis Pharmaceuticals UK Ltd for their support of this meeting. Please note that the scientific programme and content has not been influenced in any way by the sponsors.
Show Virtual / In Person rates
Agenda
View the programme (in person)
Registration, tea and coffee
Welcome and introduction
Professor Andrew Krentz, President Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Session 1: Cardiometabolic disease - clinical challenge
Chairs: Dr Abdul Lakhdar, President Elect, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Jaimini Cegla, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust
Pivotal roles of obesity and insulin resistance in cardiometabolic disease
Professor Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow, Scotland
Metabolic-associated fatty liver disease: Vascular implications
Professor Chris Byrne, Professor of Endocrinology and Metabolism, Faculty of Medicine, University of Southampton
SGLT2 inhibitors in chronic kidney disease
Professor David Wheeler, Professor of Kidney Medicine, University College London
New and emerging approaches to obesity management
Professor Alex Miras, Professor of Endocrinology, Ulster University
Tea and coffee break
Promotional symposium sponsored and organised by AstraZeneca– Simplifying the Management of Heart Failure across the ejection fraction
Professor Pardeep Jhund, Professor of Cardiology and Epidemiology, University of Glasgow
Session 2: Recent advances pharmacological interventions for cardiometabolic disorders
Chairs: Dr Sukhinder Nijjer, President, Cardiology Section, Royal Society of Medicine and Dr Paul Flynn, Addenbrooke’s Hospital, Cambridge
New pharmacotherapies for the management of dyslipidaemias
Professor Chris Packard, Senior Research Fellow, University of Glasgow, Scotland
The new treatment paradigm for type 2 diabetes – focus on cardiovascular disease
Professor Cliff Bailey, Professor Emeritus, Aston University
The new management of heart failure - the SGLT2i revolution
Professor John McMurray, Professor of Medical Cardiology, British Heart Foundation Cardiovascular Research Centre, University of Glasgow
Cardio-oncology: An emerging clinical specialty
Dr Sohaib Nazir, Consultant Cardiologist, Royal Brompton Hospital and Clinical Senior Lecturer, King's College London
Lunch break
Promotional symposium sponsored and organised by Amarin - CV Risk: Let’s Reduce-IT
Professor Derek Connolly, Honorary Senior Clinical Lecturer, Consultant Cardiologist and Director, Research and Development, Sandwell and West Birmingham Hospitals
Session 3: Breaking down the clinical silos of cardiometabolic disease management
Chairs: Professor Robert Eckel, Emeritus Professor of Medicine, Anschutz Medical Campus, University of Colorado, USA and Professor Mike Kirby, Editor, Journal Trends in Urology and Men’s Health
Peripheral arterial disease: A neglected facet of cardiometabolic disease?
Professor Christian Heiss, Cardiovascular Medicine, University of Surrey
Cardiometabolic risk: The interventional cardiology view
Professor Robert Chilton, Director, Cath Lab and Clinical Professor of Medicine, University of Texas, USA
Comprehensive non-glucocentric management of type 2 diabetes
The future of cardiometabolic disease management in primary care
Professor Samuel Seidu, Professor of Primary Care Diabetes and Cardiometabolic Medicine, University of Leicester
Tea and coffee break
Keynote Lecture
Why we need a new clinical subspeciality of cardiometabolic medicine?
Professor Robert Eckel, Emeritus Professor of Medicine, Anschutz Medical Campus, University of Colorado, USA
Closing remarks
Professor Andrew Krentz
Close of meeting
Drinks reception
View the programme (virtual)
Welcome and introduction
Professor Andrew Krentz, President Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Session 1: Cardiometabolic disease - clinical challenge
Chairs: Dr Abdul Lakhdar, President Elect, Endocrinology and Diabetes Section, Royal Society of Medicine and Dr Jaimini Cegla, Consultant in Metabolic Medicine, Imperial College Healthcare NHS Trust
Pivotal roles of obesity and insulin resistance in cardiometabolic disease
Professor Naveed Sattar, Professor of Metabolic Medicine, University of Glasgow, Scotland
Metabolic-associated fatty liver disease: Vascular implications
Professor Chris Byrne, Professor of Endocrinology and Metabolism, Faculty of Medicine, University of Southampton
Cardiovascular risk in renal disease
Professor David Wheeler, Honorary Consultant Nephrologist at Royal Free London NHS Foundation Trust and Professor of Kidney Medicine at University College London
New and emerging approaches to obesity management
Dr Alex Miras, Professor of Endocrinology, Ulster University
Comfort break
Promotional symposium sponsored and organised by AstraZeneca– Simplifying the Management of Heart Failure across the ejection fraction
Professor Pardeep Jhund, Professor of Cardiology and Epidemiology, University of Glasgow
Session 2: Recent advances Pharmacological interventions for cardiometabolic disorders
Chairs: Dr Sukhinder Nijjer, President, Cardiology Section, Royal Society of Medicine and Dr Paul Flynn, Consultant Physician, Acute and Metabolic Medicine, Addenbrooke’s Hospital, Cambridge
New approaches to dyslipidaemia
Professor Kausik Ray, Professor of Public Health, Director, Imperial Centre for Cardiovascular Disease Prevention
The new treatment paradigm the type 2 diabetes- focus on cardiovascular disease
Professor Cliff Bailey, Head of Diabetes Research, Aston University
The new management of heart failure - the SGLT2i revolution
Professor John McMurray, Professor of Medical Cardiology, British Heart Foundation Cardiovascular Research Centre, University of Glasgow
Cardio-oncology: An emerging clinical specialty
Dr Sohaib Nazir, Consultant Cardiologist, Royal Brompton Hospital and Clinical Senior Lecturer, King's College London
Lunch break
Promotional symposium sponsored and organised by Amarin - CV Risk: Let’s Reduce-IT
Professor Derek Connolly, Honorary Senior Clinical Lecturer, Consultant Cardiologist and Director, Research and Development, Sandwell and West Birmingham Hospitals
Session 3: Breaking down the clinical silos of cardiometabolic disease management
Chairs: Professor Robert Eckel, Emeritus Professor of Medicine, Anschutz Medical Campus, University of Colorado, USA and Professor Mike Kirby, Editor, Journal Trends in Urology and Men’s Health
Peripheral arterial disease: A neglected facet of cardiometabolic disease?
Professor Christian Heiss, Cardiovascular Medicine, University of Surrey
Cardiometabolic risk: The interventional cardiology view
Professor Robert Chilton, Director, Cath Lab and Clinical Professor of Medicine, University of Texas, USA
Comprehensive non-glucocentric management of type 2 diabetes
Professor Stephan Jacob, Cardiometabolic Institute
The future of primary care cardiometabolic disease management
Professor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester
Comfort break
Keynote lecture
Chair Professor Andrew Krentz, President Vascular, Lipid and Metabolic Medicine Section, Royal Society of Medicine
Why we need a new clinical subspecialty of cardiometabolic medicine?
Professor Robert Eckel, Emeritus Professor of Medicine, Anschutz Medical Campus, University of Colorado, USA
Closing remarks
Professor Andrew Krentz
Close of meeting
Sponsors
Location
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on 13 March 2023. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM's discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.